1 – 3 of 3
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Subcutaneous cladribine to treat multiple sclerosis : experience in 208 patients
(
- Contribution to journal › Article
- 2015
-
Mark
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine.
(
- Contribution to journal › Article
- 2009
-
Mark
Advanced Intercross Line Mapping Suggests That Ncf1 (Ean6) Regulates Severity in an Animal Model of Guillain-Barre Syndrome
(
- Contribution to journal › Article